Rohto Pharmaceutical Overview
- Year Founded
-
1899
- Status
-
Public
- Employees
-
11,021
- Stock Symbol
-
4527
- Investments
-
52
- Share Price
-
$16.48
- (As of Friday Closing)
Rohto Pharmaceutical General Information
Description
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
Contact Information
Website
www.rohto.co.jpCorporate Office
- 1-8-1, Tatsumi-nishi
- Ikuno-ku
- Osaka, 544-8666
- Japan
Corporate Office
- 1-8-1, Tatsumi-nishi
- Ikuno-ku
- Osaka, 544-8666
- Japan
Rohto Pharmaceutical Stock Performance
As of 20-Nov-2026, Rohto Pharmaceutical’s stock price is $16.48. Its current market cap is $3.71B with 225M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.48 | $16.70 | $14.05 - $19.60 | $3.71B | 225M | 1.26M | $0.93 |
Rohto Pharmaceutical Financials Summary
As of 30-Sep-2026, Rohto Pharmaceutical has a trailing 12-month revenue of $2.28B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 3,973,774 | 3,372,369 | 3,298,333 | 4,026,707 |
| Revenue | 2,277,706 | 2,280,479 | 2,023,795 | 1,874,457 |
| EBITDA | 412,711 | 426,937 | 358,385 | 338,280 |
| Net Income | 210,269 | 227,215 | 202,239 | 214,105 |
| Total Assets | 3,182,783 | 3,038,766 | 2,920,557 | 2,287,248 |
| Total Debt | 311,398 | 376,859 | 383,641 | 69,336 |
Rohto Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rohto Pharmaceutical Comparisons
Industry
Financing
Details
Rohto Pharmaceutical Competitors (21)
One of Rohto Pharmaceutical’s 21 competitors is Lion (Household Products), a Corporation company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lion (Household Products) | Corporation | Tokyo, Japan | ||||
| Kao | Corporation | Tokyo, Japan | ||||
| The Body Shop Cyprus | Corporation | Limassol, Cyprus | ||||
| The Body Shops | Private Equity-Backed | Littlehampton, United Kingdom | ||||
| CetaphilS | Corporation | Dusseldorf, Germany |
Rohto Pharmaceutical Patents
Rohto Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7896832-B1 | Composition containing crocetin | Active | 22-Jan-2026 | ||
| JP-7945526-B1 | Steroid-containing composition | Active | 05-Sep-2025 | ||
| JP-7876079-B1 | A composition containing dextran sulfate or its salt, royal jelly extract, and bilberry leaf extract. | Active | 27-Jun-2025 | ||
| JP-7869540-B1 | Oral composition for suppressing methane gas generation | Active | 05-Jun-2025 | ||
| JP-2026180201-A | Uv absorber-containing nanoparticles and topical compositions containing the same | Pending | 30-Apr-2025 |
Rohto Pharmaceutical Signals
Rohto Pharmaceutical Investments & Acquisitions (52)
Rohto Pharmaceutical’s most recent deal was a Merger/Acquisition with OP Bio Factory. The deal was made on 04-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| OP Bio Factory | 04-Aug-2026 | Merger/Acquisition | Consulting Services (B2B) | ||
| Magic Cod | 08-Jul-2026 | Merger/Acquisition | Personal Products | ||
| Thann Oryza | 29-May-2026 | Merger/Acquisition | Personal Products | ||
| ULUCUS PARK | 18-Apr-2026 | Early Stage VC | Education and Training Services (B2B) | ||
| NeuralPort | 08-Apr-2026 | Seed Round | Other Business Products and Services |
Rohto Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
28.13 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 84
Rank
Percentile
Rohto Pharmaceutical Exits (5)
Rohto Pharmaceutical’s most recent exit was on 13-Mar-2025 from Hutzper. The exit was categorized as with 6 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Hutzper | 13-Mar-2025 | Completed |
|
||
| Kuradashi | 06-Jul-2022 | Completed |
|
||
| Agri Holdings | 08-May-2018 | Completed |
|
||
| Flipkart Health+ | 30-May-2017 | Completed |
|
||
| Alina Vision | Corporate | Completed |
|
Rohto Pharmaceutical Affiliates
Subsidiaries (14)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Rohto Sigmapharm Holding | Vienna, Austria | 2024 | |
| Naris Cosmetics Vietnam | Hanoi, Vietnam | 2014 | |
| Magic Cod | Veternik, Serbia | 2011 | |
| OP Bio Factory | Uruma, Japan | 2006 | |
| Thann Oryza | Bangkok, Thailand | 2003 |
Rohto Pharmaceutical FAQs
-
When was Rohto Pharmaceutical founded?
Rohto Pharmaceutical was founded in 1899.
-
Where is Rohto Pharmaceutical headquartered?
Rohto Pharmaceutical is headquartered in Osaka, Japan.
-
What is the size of Rohto Pharmaceutical?
Rohto Pharmaceutical has 11,021 total employees.
-
What industry is Rohto Pharmaceutical in?
Rohto Pharmaceutical’s primary industry is Personal Products.
-
Is Rohto Pharmaceutical a private or public company?
Rohto Pharmaceutical is a Public company.
-
What is Rohto Pharmaceutical’s stock symbol?
The ticker symbol for Rohto Pharmaceutical is 4527.
-
What is the current stock price of Rohto Pharmaceutical?
As of 20-Nov-2026 the stock price of Rohto Pharmaceutical is $16.48.
-
What is the current market cap of Rohto Pharmaceutical?
The current market capitalization of Rohto Pharmaceutical is $3.71B.
-
What is Rohto Pharmaceutical’s current revenue?
The trailing twelve month revenue for Rohto Pharmaceutical is $2.28B.
-
Who are Rohto Pharmaceutical’s competitors?
Lion (Household Products), Kao, The Body Shop Cyprus, The Body Shops, and CetaphilS are some of the 21 competitors of Rohto Pharmaceutical.
-
What is Rohto Pharmaceutical’s annual earnings per share (EPS)?
Rohto Pharmaceutical’s EPS for 12 months was $0.93.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process